{
  "spec_version": "3",
  "endpoint": "segments",
  "stock_code": "4544",
  "company_name": "H.U.グループホールディングス",
  "content_lang": "ja",
  "meta_lang": "en",
  "canonical_url": "https://the-shashi.com/tse/4544/financials/",
  "api_url": "/api/4544/segments.json",
  "updated": "2026-09-05",
  "license": "© 2026 Yutaka Sugiura. All rights reserved.",
  "attribution": "The社史 (the-shashi.com) — https://the-shashi.com/tse/4544/financials/",
  "source": {
    "primary": [
      "有価証券報告書（セグメント情報）"
    ],
    "extraction": "EDINET の XBRL から機械抽出",
    "caveat": "セグメント区分は各期の開示区分をそのまま採録しており、期をまたいだ区分の連続性は保証しない"
  },
  "segment": [
    {
      "FY": "FY14",
      "period": "2015/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "ヘルスケア関連事業",
      "sales": 28358,
      "profit": 2930,
      "assets": 12815
    },
    {
      "FY": "FY14",
      "period": "2015/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "検査・関連サービス事業",
      "sales": 132853,
      "profit": 13488,
      "assets": 192251
    },
    {
      "FY": "FY14",
      "period": "2015/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "臨床検査薬事業",
      "sales": 43455,
      "profit": 10423,
      "assets": 61788
    },
    {
      "FY": "FY15",
      "period": "2016/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "ヘルスケア関連事業",
      "sales": 28823,
      "profit": 2781,
      "assets": 12123
    },
    {
      "FY": "FY15",
      "period": "2016/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "検査・関連サービス事業",
      "sales": 137130,
      "profit": 11943,
      "assets": 165379
    },
    {
      "FY": "FY15",
      "period": "2016/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "臨床検査薬事業",
      "sales": 45790,
      "profit": 10989,
      "assets": 60348
    },
    {
      "FY": "FY16",
      "period": "2017/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "ヘルスケア関連事業",
      "sales": 28606,
      "profit": 3060,
      "assets": 13263
    },
    {
      "FY": "FY16",
      "period": "2017/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "検査・関連サービス事業",
      "sales": 132935,
      "profit": 13648,
      "assets": 146222
    },
    {
      "FY": "FY16",
      "period": "2017/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "臨床検査薬事業",
      "sales": 42703,
      "profit": 11519,
      "assets": 62587
    },
    {
      "FY": "FY17",
      "period": "2018/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "ヘルスケア関連事業",
      "sales": 28130,
      "profit": 2446,
      "assets": 12368
    },
    {
      "FY": "FY17",
      "period": "2018/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "検査・関連サービス事業",
      "sales": 121958,
      "profit": 7509,
      "assets": 90863
    },
    {
      "FY": "FY17",
      "period": "2018/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "臨床検査薬事業",
      "sales": 45311,
      "profit": 9838,
      "assets": 69093
    },
    {
      "FY": "FY18",
      "period": "2019/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "ヘルスケア関連サービス事業",
      "sales": 18965,
      "profit": 967,
      "assets": 7258
    },
    {
      "FY": "FY18",
      "period": "2019/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "新規育成事業およびその他",
      "sales": 5918,
      "profit": -77,
      "assets": 6496
    },
    {
      "FY": "FY18",
      "period": "2019/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "検査・関連サービス事業",
      "sales": 111132,
      "profit": 5206,
      "assets": 87750
    },
    {
      "FY": "FY18",
      "period": "2019/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "臨床検査薬事業",
      "sales": 45399,
      "profit": 10035,
      "assets": 71466
    },
    {
      "FY": "FY19",
      "period": "2020/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "ヘルスケア関連サービス事業",
      "sales": 23505,
      "profit": 1799,
      "assets": 9205
    },
    {
      "FY": "FY19",
      "period": "2020/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "新規育成事業およびその他",
      "sales": 8238,
      "profit": -806,
      "assets": 9924
    },
    {
      "FY": "FY19",
      "period": "2020/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "検査・関連サービス事業",
      "sales": 116879,
      "profit": 5221,
      "assets": 97508
    },
    {
      "FY": "FY19",
      "period": "2020/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "臨床検査薬事業",
      "sales": 40088,
      "profit": 6089,
      "assets": 72589
    },
    {
      "FY": "FY20",
      "period": "2021/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "ヘルスケア関連サービス事業",
      "sales": 32087,
      "profit": 2332,
      "assets": 14748
    },
    {
      "FY": "FY20",
      "period": "2021/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "検査・関連サービス事業",
      "sales": 140898,
      "profit": 12610,
      "assets": 124553
    },
    {
      "FY": "FY20",
      "period": "2021/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "臨床検査薬事業",
      "sales": 50030,
      "profit": 12782,
      "assets": 83847
    },
    {
      "FY": "FY21",
      "period": "2022/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "ヘルスケア関連サービス事業",
      "sales": 28676,
      "profit": 1801,
      "assets": 13076
    },
    {
      "FY": "FY21",
      "period": "2022/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "検査・関連サービス事業",
      "sales": 179932,
      "profit": 23630,
      "assets": 142092
    },
    {
      "FY": "FY21",
      "period": "2022/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "臨床検査薬事業",
      "sales": 64335,
      "profit": 26732,
      "assets": 105588
    },
    {
      "FY": "FY22",
      "period": "2023/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "ヘルスケア関連サービス事業",
      "sales": 27755,
      "profit": 1057,
      "assets": 13822
    },
    {
      "FY": "FY22",
      "period": "2023/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "検査・関連サービス事業",
      "sales": 163093,
      "profit": 279,
      "assets": 131136
    },
    {
      "FY": "FY22",
      "period": "2023/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "臨床検査薬事業",
      "sales": 70059,
      "profit": 26528,
      "assets": 129170
    },
    {
      "FY": "FY23",
      "period": "2024/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "ヘルスケア関連サービス事業",
      "sales": 28311,
      "profit": 1337,
      "assets": 13121
    },
    {
      "FY": "FY23",
      "period": "2024/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "検査・関連サービス事業",
      "sales": 146730,
      "profit": -12512,
      "assets": 117902
    },
    {
      "FY": "FY23",
      "period": "2024/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "臨床検査薬事業",
      "sales": 61908,
      "profit": 12915,
      "assets": 124646
    },
    {
      "FY": "FY24",
      "period": "2025/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "ヘルスケア関連サービス事業",
      "sales": 29518,
      "profit": 1777,
      "assets": 14151
    },
    {
      "FY": "FY24",
      "period": "2025/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "検査・関連サービス事業",
      "sales": 153014,
      "profit": -4638,
      "assets": 108603
    },
    {
      "FY": "FY24",
      "period": "2025/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "臨床検査薬事業",
      "sales": 60492,
      "profit": 11345,
      "assets": 107957
    }
  ]
}